Show simple item record

Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.

dc.contributor.authorSILPA-ARCHA, S
dc.contributor.authorOray, Merih
dc.contributor.authorFOSTER, CS
dc.contributor.authorPREBLE, JM
dc.date.accessioned2021-03-05T19:52:20Z
dc.date.available2021-03-05T19:52:20Z
dc.identifier.citationSILPA-ARCHA S., Oray M., PREBLE J., FOSTER C., "Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.", Acta ophthalmologica, cilt.94, 2016
dc.identifier.issn1755-375X
dc.identifier.othervv_1032021
dc.identifier.otherav_d14d4d4d-84cc-4918-9c9d-c714e7561194
dc.identifier.urihttp://hdl.handle.net/20.500.12627/138357
dc.identifier.urihttps://doi.org/10.1111/aos.13015
dc.language.isoeng
dc.titleOutcome of tocilizumab treatment in refractory ocular inflammatory diseases.
dc.typeMakale
dc.relation.journalActa ophthalmologica
dc.contributor.department, ,
dc.identifier.volume94
dc.identifier.endpage6
dc.contributor.firstauthorID176974


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record